CSF and blood Kallikrein-8: a promising early biomarker for Alzheimer’s disease

OBJECTIVE: There is still an urgent need for supportive minimally invasive and cost-effective biomarkers for early diagnosis of Alzheimer’s disease (AD). Previous work in our lab has identified Kallikrein-8 (KLK8) as a potential candidate since it shows an excessive increase in human brain in precli...

Descripción completa

Detalles Bibliográficos
Autores principales: Teuber-Hanselmann, Sarah, Rekowski, Jan, Vogelgsang, Jonathan, von Arnim, Christine, Reetz, Kathrin, Stang, Andreas, Jöckel, Karl-Heinz, Wiltfang, Jens, Esselmann, Herrmann, Otto, Markus, Tumani, Hayrettin, Herring, Arne, Keyvani, Kathy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Neurodegeneration
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952834/
https://www.ncbi.nlm.nih.gov/pubmed/31371645
http://dx.doi.org/10.1136/jnnp-2019-321073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952834/
https://www.ncbi.nlm.nih.gov/pubmed/31371645
http://dx.doi.org/10.1136/jnnp-2019-321073

Ejemplares similares